{"id":578255,"date":"2017-09-28T00:00:00","date_gmt":"2017-09-28T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/epidrs0001-2017-biopharma-strategic-vaccines-epidemiology-vaccines-epidemiology-forecaster\/"},"modified":"2026-04-15T23:25:38","modified_gmt":"2026-04-15T23:25:38","slug":"epidrs0001-2017-biopharma-strategic-vaccines-epidemiology-vaccines-epidemiology-forecaster","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/epidrs0001-2017-biopharma-strategic-vaccines-epidemiology-vaccines-epidemiology-forecaster\/","title":{"rendered":"Strategic Vaccines &#8211; Epidemiology &#8211; Vaccines Epidemiology Forecaster"},"content":{"rendered":"<p>The Vaccines Epidemiology Forecaster allows you to interactively assess\u00a0assumptions about vaccine launch dates and the time taken to reach the current coverage of a particular vaccine group in a specified country in order to size the potential patient population a vaccine could reach.<\/p>\n<p><strong>QUESTIONS ANSWERED<\/strong><\/p>\n<ul>\n<li>What is the addressable market for vaccines in development, and how will that change over time?<\/li>\n<li>What is the current coverage of a vaccine in a specific country?<\/li>\n<li>What assumptions can I make for a new vaccine launch based on comparator products in a given country or region?<\/li>\n<\/ul>\n<p><strong>GEOGRAPHIES<\/strong><\/p>\n<ul>\n<li>Global, with additional granularity for the G7<\/li>\n<\/ul>\n<p><strong>EPIDEMIOLOGY<\/strong><\/p>\n<ul>\n<li>Patient population data by country or region and income status, with an algorithm to make extrapolations for missing data on vaccine coverage, based on similarities in GDP.<\/li>\n<\/ul>\n<p><strong>COVERAGE<\/strong><\/p>\n<ul>\n<li>Vaccine coverage includes:\u00a0BCG, DTP, polio, hep B (birth dose), HPV, Japanese encephalitis, MCV, rota, yellow fever<\/li>\n<\/ul>\n<p><strong>DATA &#038; FEATURES<\/strong><\/p>\n<ul>\n<li>Delivered as a stand-alone Excel model based on DRG\u2019s gold-standard epidemiology for vaccine coverage.<\/li>\n<li>G7 dashboard facilitates a more-granular analysis in the mature markets.<\/li>\n<li>Options to incorporate additional primary or secondary data and customizable deliverables.<\/li>\n<li>Access to DRG\u2019s expert epidemiologists for bespoke support.<\/li>\n<\/ul>\n","protected":false},"template":"","class_list":["post-578255","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-product-epidemiology","biopharma-date-890"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/578255","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/578255\/revisions"}],"predecessor-version":[{"id":578304,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/578255\/revisions\/578304"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=578255"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}